Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

Publisher： Karger

E-ISSN： 1421-9662|130|3|192-195

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.3, 2013-06, pp. : 192-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-03 ,pp. : 30-39

Karger

Access to resources Recommend Favorite

Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : E146-E148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead

By  

Acta Haematologica, Vol. 136, Iss. 1, 2016-05 ,pp. : 43-44

Karger

Access to resources Recommend Favorite

Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 364-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3894-3904

John Wiley & Sons Inc

Access to resources Recommend Favorite